ESR1 and breast cancer: Further, in ER+BC with estrogen receptor alpha mutations that lead to constitutive activation and ligand independent signaling, obASCs were shown to promote metastasis but not proliferation or tumor growth compared to lnASCs or cell grafts without ASCs [21].